NeoPharm Presents The Phase II Data Of Liposome-Entrapped Paclitaxel (LEP) In Patient
NeoPharm, Inc. (Other OTC: NEOL.PK) announced the results of a Phase II clinical trial of Liposome-Entrapped Paclitaxel (LEP) an active component of Taxol®. This multicenter, open-label trial of LEP was conducted at 5 centers in India...